Page 25 - உயிரி தொழில்நுட்பவியல் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(Pixabay) Thanks to COVID and virus research, a new mRNA ‘Vaccine Treatment’ for MS is in final development. The Multiple Sclerosis Society of Canada made the announcement in their January 25, 2021 Newsletter. They wrote: “BioNTech is Applying mRNA Vaccine Technology to Treat Multiple Sclerosis. BioNTech, a German biotechnology company that is working with Pfizer to develop a COVID-19 vaccine, reports that they are using the same technology to develop a therapeutic approach to multiple sclerosis (MS).” Jan. 25, 2021 Yahoo Finance Reports on BioNTech; “With the MS vaccine, the mRNA technology stops the body s immune system from attacking neurons in the brain and spinal cord.”

Derrick rossiSclerosis society of canadaRna vaccine technology to treat multiple sclerosisBiontech biotechnology companyVirus researchVaccine treatmentMultiple sclerosis societyTreat multipleFinance reportsPersonal contactMedical professionVirus theoryBone diseaseBiotechnology companyCanadian derrick rossiடெரிக் ரோஸி